Petros Pharmaceuticals SG&A Expense (TTM) Analysis

Petros Pharmaceuticals Inc (PTPI)

0.4575 +0.01 (+2.69%) USD | NASDAQ | Jun 28, 16:00

0.448 -0.01 (-2.08%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	9.842M
December 31, 2023	9.262M
September 30, 2023	9.306M
June 30, 2023	9.475M
March 31, 2023	10.44M
December 31, 2022	12.21M
September 30, 2022	13.47M

Date	Value
June 30, 2022	14.71M
March 31, 2022	15.61M
December 31, 2021	15.59M
September 30, 2021	15.09M
June 30, 2021	14.80M
March 31, 2021	14.74M
December 31, 2020	15.68M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

9.262M

Minimum

Dec 2023

15.68M

Maximum

Dec 2020

12.87M

Average

14.09M

Median

SG&A Expense (TTM) Benchmarks